Cyclo Therapeutics (OTCMKTS:CTDH) Sets New 12-Month High at $7.15

Cyclo Therapeutics, Inc. (OTCMKTS:CTDH) hit a new 52-week high during trading on Monday . The company traded as high as $7.15 and last traded at $6.47, with a volume of 166116 shares traded. The stock had previously closed at $7.10.

The stock has a 50-day moving average of $8.11 and a 200 day moving average of $8.51.

About Cyclo Therapeutics (OTCMKTS:CTDH)

Cyclo Therapeutics, Inc, a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Featured Article: Stock Symbols and CUSIP Explained

Receive News & Ratings for Cyclo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.